Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) In 2022: Will It Be Worth Investing In?

This post was originally published on this site

In the last trading session, 1.36 million shares of the Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) were traded, and its beta was 0.61. Most recently the company’s share price was $0.44, and it …